NCT07750886
- Conditions
- Anaplastic Large Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, +22 more
- Locations
-
- Natera, Inc. Austin, Texas, United States
Clinical trial condition
Lymphoma, B-Cell
Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.
1,639 public trials
336 recruiting studies
Lymphoma, B-Cell trial results
NCT06116110
- Conditions
- Central Nervous System Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
- Locations
-
- Stanford University Stanford, California, United States
- Yale University New Haven, Connecticut, United States
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT07069699
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Double-Expressor Lymphoma, +16 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- University of Kansas Clinical Research Center Fairway, Kansas, United States
- University of Kansas Cancer Center Kansas City, Kansas, United States
Recruiting
Blinatumomab Consolidation in Real World
NCT07117136
- Conditions
- B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Mayo Clinic Cancer Center Jacksonville, Florida, United States
- Medical College of Wisconsin Milwaukee, Wisconsin, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT06708897
- Conditions
- Blood Protein Disorders, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +32 more
- Locations
-
- Norton Cancer Institute, St. Matthews Campus Louisville, Kentucky, United States
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
- University of Cincinnati Cincinnati, Ohio, United States
- The Ohio State University Columbus, Ohio, United States
NCT01804686
- Conditions
- Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +43 more
- Locations
-
- City of Hope Cancer Center Duarte, California, United States
- University of California San Diego Medical Center La Jolla, California, United States
- University of California Los Angeles Los Angeles, California, United States
- St. Joseph Hospital Center for Cancer Prevention and Treatment Orange, California, United States
Recruiting
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
NCT07609862
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
NCT07424833
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +33 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Henan Cancer Hospital Zhengzhou, Henan, China
- START Los Angele Los Angeles, California, United States
- START Midwest Grand Rapids, Michigan, United States
NCT07197307
- Conditions
- Aggressive Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL) Grade 3B, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany
- Universitaetsklinikum Aachen Aachen, Germany
- Universitaetsklinikum Augsburg Augsburg, Germany
- Vivantes Netzwerk fuer Gesundheit Berlin, Germany
NCT06785818
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +17 more
- Locations
-
- Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
- Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
- Novartis Investigative Site Gyeonggi-do, Korea, South Korea
- Novartis Investigative Site Incheon, Korea, South Korea